U.S. Markets closed

Alcobra (ADHD) Jumps: Stock Rises 8.5%

Zacks Equity Research

Alcobra Ltd. (ADHD) was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.95 to $22.79 in the past one-month time frame.

The company has seen one negative estimate revision in the past 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Alcobra currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, some better-ranked medical stocks include Auxilium Pharmaceuticals Inc. (AUXL), BioSpecifics Technologies Corp. (BSTC) and Lannett Company, Inc. (LCI) All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALCOBRA LTD ORD (ADHD): Free Stock Analysis Report


BIOSPECIFICS TECH CORP (BSTC): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report

Zacks Investment Research